Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 27, 2024HereditasOpen Access

Bioinformatic analysis and experimental validation of cuproptosis-related LncRNA as a novel biomarker for prognosis and immunotherapy of oral squamous cell carcinoma

View Full Paper
Ask AI
Bookmark
Share

Authors

SLShuang LiangLJLanting JiZYZhenyuan Yu

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Liang et al. (2024) studied this question.

synapsesocial.com/papers/68e77584b6db6435876eab2dhttps://doi.org/10.1186/s41065-024-00311-5
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma2022 · 64 citations
  2. 2A new cuproptosis-associated lncRNA signature predicts the prognosis of clear cell renal cell carcinoma patients2026
  3. 3A cuproptosis-related lncRNAs signature predicts prognosis and reveals pivotal interactions between immune cells in colon cancer2024 · 3 citations
  4. 4Identification of a novel necroptosis-related LncRNA signature for prognostic prediction and immune response in oral squamous cell carcinoma2024 · 1 citations
  5. 5Novel cuproptosis related long non-coding RNA signature in oral squamous cell carcinoma prognosis and immunotherapy2026